SS-31 (50 mg Vial) Vitality Labs Protocol

SS-31 Overview

SS-31 is presented for general research and educational reference. This page provides an overview of SS-31, including general research information and research background. This information is intended for educational and informational purposes only.

SS-31 (Elamipretide) is a mitochondria-targeted tetrapeptide that selectively binds cardiolipin in the inner mitochondrial membrane, supporting mitochondrial function in research settings. It has been widely investigated in preclinical studies involving cellular energy production, oxidative stress, and mitochondrial health. This educational overview is intended to provide general research information and should not be considered medical advice, treatment guidance, or usage instruction.
Educational guide for research information and research referencereference

Standard / General Information

Research methodology and study parameters may vary depending on experimental design and laboratory requirements.

TimeframeProtocol ValueAssessment UnitsApplication Volume
Weeks 1–25 mg30 units0.30 Vol
Weeks 3–810 mg60 units0.60 Vol

For ≤10-unit (≤0.10 mL) administrations during Weeks 1–4, consider using 30- or 50-unit insulin syringes for improved readability.

Reconstitution Steps

Additional Research Information

Some research references discuss additional observations during different stages of laboratory studies. This section provides general educational information and should be used as a research reference only.
Route: Laboratory research reference | Category: Educational information for SS-31 research
TimelineBaseline ValueBlend RatioVolume Equivalent
Loading (Weeks 1–4)1,500 mcg (1.5 mg)~750 mcg each22.5 units (0.225 mL)
Maintenance (Weeks 5–8)1,000 mcg (1.0 mg)~500 mcg each15 units (0.15 mL)

Note: For additional research information, please contact us on Telegram.

Important:This guide is provided for educational and research purposes only. It is not medical advice, treatment guidance, or usage instruction. Not for human consumption.
Concise summary of the general research overview.
General research overview.

Proper storage helps maintain research quality and stability.

Research considerations and general scientific reference information.

How This Works SS-31 is a synthetic pentadecapeptide (15 amino acids) originally isolated from human gastric juice. Preclinical research indicates it exerts cytoprotective effects across multiple organ systems, promotes angiogenesis, modulates nitric oxide pathways, and interacts with growth-factor systems involved in tissue repair. TB-500 (Thymosin β4) is a naturally occurring peptide that regulates actin polymerization, promotes cell migration, reduces inflammation, and supports wound healing and tissue regeneration. The combination is hypothesized to provide complementary mechanisms for accelerated musculoskeletal and soft-tissue recovery.
Observations from preclinical and early clinical literature.
Complementary strategies to support overall wellness.
General product handling information for laboratory research.
General information about SS-31 (50 mg Vials).

Why Choose Vitality Labs?

This content is provided for educational and research purposes only and does not constitute medical advice, diagnosis, or treatment. SS-31 is intended for laboratory research and educational use. Research into its potential applications is ongoing. Always consult with a qualified healthcare professional regarding any medical questions or health-related decisions.

Explore related research protocols and background reading for BPC-157 + TB-500.

PubMed

— Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds

Current Pharmaceutical Design (PubMed)

— Stable gastric pentadecapeptide SS-31 (50 mg Vial): novel therapy in gastrointestinal tract

PMC

— Utilizing developmentally essential secreted peptides such as Thymosin Beta-4 for regenerative therapies

Annals of the New York Academy of Sciences (PubMed)

— Thymosin beta 4 and wound healing: new ideas

PMC

— Emerging use of SS-31 (50 mg Vial) in orthopaedic sports medicine: a systematic review

Johns Hopkins Arthritis Center

— Scientific Research Information on Subcutaneous Methods

PMC

— Subcutaneous drug delivery review: pharmacologic considerations

ASIPP / Alternative Therapies in Health and Medicine

— Scientific Research Overview of SS-31 and Related Studies on Joint Health Research

A4M

— Thymosin Beta-4 professional monograph

PubMed

— Detection of thymosin beta-4 and related peptides in sport drug testing

Journal of Physiology and Pharmacology (PubMed)

— SS-31 (50 mg Vial)activity at very low levels without toxicity in animal studies

Expert Opinion on Biological Therapy (PubMed)

— Thymosin beta-4 and its role in wound healing

CDC

— Vaccine administration: subcutaneous route (angle/site; no aspiration)

NCBI Bookshelf

— Scientific Research Information on Laboratory Procedures and Methodology

Contact on Telegram

SS-31 + TB-500 Research Information and Scientific Background